Compositions that specifically bind to colorectal cancer cells and methods of using the same
US6087109A · kind A · utility
5Cited by
17References
19Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 17, 1998 |
| Grant date | Jul 11, 2000 |
| Priority date | — |
| Expiry date | Nov 17, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Conjugated compounds that comprise an ST receptor binding moiety and an active moiety that is an antisense molecule are disclosed. Pharmaceutical compositions which comprise conjugated compounds that comprise an ST receptor binding moiety and an active moiety that is an antisense molecule are disclosed including pharmaceutical compositions that have enteric formulations. Methods of treating an individual suspected of suffering from colorectal cancer and methods of preventing colorectal cancer are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.